Hoa G Pham, PHARMD - Pharmacist in Carrollton, TX

Hoa G Pham, PHARMD is a Pharmacist based in Carrollton, Texas. Hoa G Pham is licensed to practice in Texas (license number 47779) and his current practice location is 4038 Old Denton Rd, Carrollton, Texas. He can be reached at his office (for appointments etc.) via phone at (763) 670-1277.

NPI number for Hoa G Pham is 1043592199 and his current mailing address is 4038 Old Denton Rd, Carrollton, Texas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1043592199.

Contact Information

Hoa G Pham, PHARMD
4038 Old Denton Rd,
Carrollton, TX 75007-1020
(763) 670-1277
Not Available

Healthcare Provider's Profile

Full NameHoa G Pham
GenderMale
SpecialityPharmacist
Location4038 Old Denton Rd, Carrollton, Texas
Accepts Medicare AssignmentsDoes not participate in Medicare Program. He may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1043592199
  • Provider Enumeration Date: 09/14/2011
  • Last Update Date: 05/11/2012

Medical Identifiers

Medical identifiers for Hoa G Pham such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1043592199NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 47779 (Texas)Primary
183500000XPharmacist 118553 (Minnesota)Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Hoa G Pham is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Hoa G Pham, PHARMD
4038 Old Denton Rd,
Carrollton, TX 75007-1020

Ph: (763) 670-1277
Hoa G Pham, PHARMD
4038 Old Denton Rd,
Carrollton, TX 75007-1020

Ph: (763) 670-1277

News Archive

Telmisartan reduces hypertension, cardiovascular risk in ACE-intolerant patients: Boehringer Ingelheim

Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient years. Convincing safety data for patients with a high cardiovascular risk were collected in the three long-term outcome trials ONTARGET, PRoFESS and TRANSCEND which followed some of the patients for up to five years.

Face recognition abilities apparent in fetuses

Recent research into foetal behaviour using 4D ultrasound technology indicates that a foetus in the third trimester can recognise and respond to face-like shapes.

HHS unveils MLR rule

The Department of Health and Human Services today released its final medical loss ratio rule. According to an HHS press release, the rule will ensure that health insurance companies spend at least 80 percent of consumers' health insurance premiums on medical care rather than on income, overhead and marketing expenses.

Genetic mutation that alters PIEZO1 ion channel in RBCs contributes to familial xerocytosis

A genetic mutation that alters the kinetics of an ion channel in red blood cells has been identified as the cause behind a hereditary anemia, according to a paper published this month in the Proceedings of the National Academy of Sciences by University at Buffalo scientists and colleagues.

Researchers receive $3M R01 award to test new approach to treating brain tumors

With a five-year, $3 million R01 award from the National Institutes of Health, through the National Cancer Institute, a team of researchers led by Gregory Fischer, PhD, assistant professor of mechanical engineering and robotics engineering at Worcester Polytechnic Institute and director of WPI's Automation and Interventional Medicine Laboratory, will test a new, minimally invasive approach to treating brain tumors that promises to accurately destroy malignant tissue while leaving surrounding tissue unaffected.

Read more News

› Verified 7 days ago


Pharmacist in Carrollton, TX

Dr. Gabriel Castaneda,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006
Phone: 432-553-2286    
Sem Ee Kwon,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1804 E Hebron Pkwy, Carrollton, TX 75010
Phone: 972-939-1977    
Dr. Han Ngoc Nguyen, PHARM.D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 4038 Old Denton Rd, Carrollton, TX 75007
Phone: 972-512-3366    
Gina Rosson,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006
Phone: 800-508-0960    
Aaron Broadwell,
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006
Phone: 800-273-3455    
Rekha Daniel, PHARM D
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1025 W Trinity Mills Rd, Carrollton, TX 75006
Phone: 800-508-0960    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.